01 5Fragmin
Main Therapeutic Indication : Hematology
Currency : USD
2019 Revenue in Millions : 253
2018 Revenue in Millions : 293
Growth (%) : -14
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 252
2019 Revenue in Millions : 253
Growth (%) : 0
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 305
2020 Revenue in Millions : 252
Growth (%) : 21
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 269
2021 Revenue in Millions : 305
Growth (%) : -12
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 238
2022 Revenue in Millions : 269
Growth (%) : -12
LOOKING FOR A SUPPLIER?